drugset / Trial / NCT00640835
Safety and Tolerability of Buprenorphine/Naloxone Film Strips
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability on the oral mucosa of buprenorphine/naloxone film strips administered either sublingually or buccally daily for 12 weeks in opioid dependent individuals who are already on a stable regimen of buprenorphine/naloxone.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 4 mg | Subcutaneous |
| Subject | Buprenorphine | Other / unclassified | 32 mg | Subcutaneous |
| Subject | Naloxone | Small molecule | 1 mg | Subcutaneous |
| Subject | Naloxone | Small molecule | 8 mg | Subcutaneous |